Deoxynucleoside triphosphate incorporation mechanism of Foamy Virus (FV) reverse transcriptase: Implications for cell tropism of FV

Journal of Virology

Volumn 82, Issue 16, 2008, Pages 8235-8238

  Santos Velazquez, Jose ^a   Kim, Baek ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYNUCLEOSIDE TRIPHOSPHATE; PHOSPHATE; RNA DIRECTED DNA POLYMERASE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SPUMA VIRUS; STEADY STATE;

BINDING SITES; DNA PRIMERS; DNA-DIRECTED DNA POLYMERASE; HIV-1; HUMANS; KINETICS; MACROPHAGES; MITOSIS; MOLONEY MURINE LEUKEMIA VIRUS; MUTATION; NUCLEOTIDES; RNA-DIRECTED DNA POLYMERASE; SPUMAVIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; PRIMATES;

EID: 49149119965     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00088-08     Document Type: Article

References (15)

1. Boyer, P. L., C. R. Stenbak, P. K. Clark, M. L. Linial, and H. S. Hughes. 2004. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase. J. Virol. 78:6112-6121.
2. Diamond, T. L., M. Roshal, V. K. Jamburuthugoda, H. M. Reynolds, A. R. Merriam, K. Y. Lee, M. Balakrishnan, R. A. Bambara, V. Planelles, S. Dewhurst, and B. Kim. 2004. Macrophage tropism of HIV-1 depends upon efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279:51545-51553.
3. Jamburuthugoda, V. K., P. Chugh, and B. Kim. 2006. Modification of human immunodeficiency virus type 1 reverse transcriptase to target cells with elevated cellular dNTP concentrations. J. Biol. Chem. 281:13388-13395.
4. Jamburuthugoda, V. K., D. Guo, J. E. Wedekind, and B. Kim. 2005. Kinetic evidence for interaction of human immunodeficiency virus type 1 reverse transcriptase with the 3′-OH of the incoming dTTP substrate. Biochemistry 44:10635-10643.
5. Johnson, K. A. 1993. Conformational coupling in DNA polymerase fidelity. Annu. Rev. Biochem. 62:685-713.
6. Johnson, K. A. 1995. Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates. Methods Enzymol. 249:38-61.
7. Kim, B. 1997. Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants. Methods 12:318-324.
8. Linial, M. L. 1999. Foamy viruses are unconventional retroviruses. J. Virol. 73:1747-1755.
9. Löchelt, M., S. F. Yu, M. L. Linial, and R. M. Flügel. 1995. The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 206:601-610.
10. Operario, D. J., H. M. Reynolds, and B. Kim. 2005. Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases. Virology 335:106-121.
11. Saïb, A., and H. de Thé. 1996. Molecular biology of the human foamy virus. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:S254-260.
12. Skasko, M., K. K. Weiss, H. M. Reynolds, V. Jamburuthugoda, K. Lee, and B. Kim. 2005. Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases. J. Biol. Chem. 280:12190-12200.
13. Trobridge, G., and D. W. Russell. 2004. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J. Virol. 78:2327-2335.
14. Weiss, K. K., R. A. Bambara, and B. Kim. 2002. Mechanistic role of residue GIn 151 in error prone DNA synthesis by human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Pre-steady state kinetic study of the Q151N HIV-1 RT mutant with increased fidelity. J. Biol. Chem. 277:22662-22669.
15. Weiss, K. K., R. Chen, M. Skasko, H. M. Reynolds, K. Lee, R. A. Bambara, L. M. Mansky, and B. Kim. 2004. A Role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry 43:4490-4500.